cycloheximide has been researched along with zithromax in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Beckers, CJ; Cao, Y; Donald, RG; Joiner, KA; Luft, BJ; Roos, DS; Schwab, JC | 1 |
| Hong, KC; House, J; Lietman, TM; Moncada, J; Schachter, J; Zhou, Z | 1 |
3 other study(ies) available for cycloheximide and zithromax
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Base Sequence; Clindamycin; Cycloheximide; Cytoplasm; DNA, Mitochondrial; Electrophoresis, Gel, Two-Dimensional; Lincosamides; Macrolides; Molecular Sequence Data; Organelles; Plastids; Protein Synthesis Inhibitors; Protozoan Proteins; Sequence Homology, Nucleic Acid; Tetracycline; Toxoplasma | 1995 |
Lack of macrolide resistance in Chlamydia trachomatis after mass azithromycin distributions for trachoma.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Chlamydia trachomatis; Cycloheximide; Drug Resistance, Microbial; Ethiopia; Eye Diseases; Female; Genetic Predisposition to Disease; Humans; Infant; Male; Pregnancy; Pregnancy Complications, Infectious; Prevalence | 2009 |